Feb 9 (Reuters)-
D.Western Therapeutics Institute Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2023 Dec 31, 2022 Dec 31, 2024 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 428 mln 448 mln 400 mln
(-4.4 pct) (+8.1 pct) (-6.6 pct)
Operating loss 798 mln loss 305 mln loss 1.50
Recurring loss 796 mln loss 295 mln loss 1.51
Net
Net loss 812 mln loss 429 mln loss 1.51
EPS loss 25.56 yen loss 14.50 yen loss 47.00 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - D.Western Therapeutics Institute Inc.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4576.T